首页 | 本学科首页   官方微博 | 高级检索  
     

FasL、B7-1联合基因修饰的胃癌细胞诱导抗胃癌主动免疫的研究
引用本文:郑世营,赵军,葛锦锋,王志刚,王慧穆,李小兵. FasL、B7-1联合基因修饰的胃癌细胞诱导抗胃癌主动免疫的研究[J]. 中华实验外科杂志, 2003, 20(12): 1106-1108
作者姓名:郑世营  赵军  葛锦锋  王志刚  王慧穆  李小兵
作者单位:215006,苏州大学附属第一医院胸心外科
基金项目:江苏省医学科技发展基金重点资助项目(H.200147)
摘    要:目的 探讨FasL、B7-1联合基因转移是否具有协同的抗肿瘤效应。方法 采用重组腺病毒载体将FasL、B7-1基因导入人胃癌细胞SGC-7901,G418阳性克隆筛选,流式细胞分析,逆转录-聚合酶链反应(RT-PCR),显示FasL和B7-1的表达,并且通过Hoechst33342染色检测胃癌细胞凋亡;将携带 FasL和 B7-1基因的胃癌细胞(命名为 SGC-7901/FB-11)接种于 C57BL/6小鼠背部皮下,观测其致瘤性能;SGC-7901/FB-11致敏的小鼠对野生型瘤细胞是否具有免疫保护作用;用SGC-7901和 SGC-7901/FB-11细胞分别经腹腔免疫小鼠,得到腹腔浸润淋巴细胞及致敏脾细胞,MTT法检测其体外杀伤实验。结果 FasL和B7-1基因在胃癌细胞中获得高表达并可诱导胃癌细胞的凋亡,双基因转染的胃癌细胞的致瘤性明显下降;SGC-7901/FB-11诱导的细胞毒T淋巴细胞(CTL)对SGC-7901的杀伤活性显著高于野生型SGC-7901诱导的CTL对相同靶细胞的杀伤活性(P<0.05);SGC-7901/FB-11诱导的 CTL对 SGC-7901/FB-11的杀伤率显著高于对野生型 SGC-7901的杀伤率(P<0.05)。结论 FasL促进胃癌细胞凋亡,B7-1促进抗胃癌CTL的增殖、活化,在效应阶段两基因发挥着重要的协同作用。

关 键 词:FasL B7-1 基因修饰 胃癌 主动免疫 癌细胞 基因治疗
修稿时间:2003-02-19

Active immunity of anti-gastric cancer induced by FasL and B7-1 gene modified tumor cells
ZHENG Shi-ying,ZHAO Jun,GE Jin-feng,et al.. Active immunity of anti-gastric cancer induced by FasL and B7-1 gene modified tumor cells[J]. Chinese Journal of Experimental Surgery, 2003, 20(12): 1106-1108
Authors:ZHENG Shi-ying  ZHAO Jun  GE Jin-feng  et al.
Affiliation:ZHENG Shi-ying,ZHAO Jun,GE Jin-feng,et al. Department of Thoracocardiac Surgery,The First Affiliated Hospital of Suzhou University,Suzhou 215006,China
Abstract:Objective To study the activation of CTLs against gastric cancer cells induced byFasL and B7-1 gene modified tumor cells and to explore whether co-expression of FasL and B7-1 in SGC-7901 tumor cells could initiate an synergistic antitumor effect. Methods FasL and B7-1 genes weretransfected into human gastric cancer SGC-7901 cells mediated with adenovirus. The positive clones wereselected by G418. The flow cytometry and RT-PCR were used for detection of the FasL and B7-1 expres-sion. FasL + /B7-1 + SGC-7901 (SGC-7901/FB-11) cells were inoculated into the back of C57BL/6mice subcutaneously for observation of their tumorigenicity. The SGC-7901/FB-11 cell sensitized miceobtained the protective immune activity against the rechanllenge of wild type SGC-7901 cells. The ab-dominal infiltrating lymphocytes and sensitized spleen cells were obtained from the mice immunized withSGC-7901/FB-11 or wild type SGC-7901 cells intraperitoneally, and the cytotoxicity of these CTLs a-gainst tumor cells was detected by MTT assay. Results FasL and B7-1 genes were highly expressed ingastric cancer cells and could induce the apoptosis of gastric cancer cells. The gastric cancer cells withtransfection of FasL and B7-1 genes had a significantly decreased tumorigenicity. The cytotoxicity of CTLinduced by SGC-7901/FB-11 against SGC-7901 was significantly higher than that by wild SGC-7901 a-gainst the same target cells (P < 0.05). Conclusion The FasL and B7-1 can effectively promote the ac-tivity of CTL against gastric cancer cells. FasL/B7-1 molecules play an important role in CTL cytotoxicityfunction as well. After introduced into SGC-7901 cells, Ad-B7-1 shows enhanced therapeutic efficiency forSGC-7901 cells when combined with Ad-FasL.
Keywords:Gastric carcinoma  Gene therapy  Apoptosis
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号